Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06821776 · ClinicalTrials.gov registry record · NA

Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study

A NA study of Bronchopulmonary Dysplasia and Feeding Intolerance, sponsored by Le Bonheur Children's Hospital.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06821776: Recruiting NA study of Bronchopulmonary Dysplasia and Feeding Intolerance, sponsored by Le Bonheur Children's Hospital.

NCT06821776 is a NA study of Bronchopulmonary Dysplasia and Feeding Intolerance that is actively recruiting participants, run by Le Bonheur Children's Hospital. The registered enrollment target is 25 participants, below the 235-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06821776, a NA study of Bronchopulmonary Dysplasia and Feeding Intolerance, is actively recruiting participants, sponsored by Le Bonheur Children's Hospital.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode. Respiratory status will be assessed to determine the optimal feeding mode for each infant.

Primary Outcome

RSS (the product of mean airway pressure and oxygen fraction) will be calculated before and after each 2-week intervention block.

Interventions

  • PROCEDURE Gastric feeding
  • PROCEDURE Transpyloric feeding

Study Locations (1)

Tennessee

  • Le Bonheur Children's Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-02-05
Est. Completion 2030-02
Phase NA
Le Bonheur Children's Hospital

14 total trials

What NCT06821776 shows while recruiting

NCT06821776 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 235-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Gastric feeding is the first listed.

NCT06821776 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06821776 about?

NCT06821776 is a clinical study titled "Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study". Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode. Respiratory status will be assess...

What is the current status of trial NCT06821776?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-02-05. Estimated completion is 2030-02.

What conditions does trial NCT06821776 study?

This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Feeding Intolerance.

What interventions are being tested in trial NCT06821776?

The interventions under investigation include: Gastric feeding (PROCEDURE), Transpyloric feeding (PROCEDURE).

Who is sponsoring clinical trial NCT06821776?

This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06821776 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchopulmonary Dysplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06821776's enrollment target sits among peer trials

25 26th of 29 higher than 4 of 29 other Bronchopulmonary Dysplasia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06821776, the US trial registry maintained by the National Library of Medicine. NCT06821776 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.